Gmax Biopharm
Gmax Biopharm develops GPCR antibody therapeutics for unmet medical needs in cardiovascular diseases, metabolic disorders, and cancer.
Gmax Biopharm is a business in biotechnology, clinical trials, health care, product research based in Asia-Pacific (APAC), founded in 2010.
The company sits in the biotechnology, clinical trials, health care, product research segment, where it competes on its core product or service.
Its base of operations is Asia-Pacific (APAC).
Directory data places it at the Series_C stage.
Its team size is recorded as c_00011_00050 employees.
Public records show total funding of about $78M.
| Sector | Biotechnology, Clinical Trials, Health Care, Product Research |
|---|---|
| Headquarters | Asia-Pacific (APAC) |
| Founded | 2010 |
| Employees | c_00011_00050 |
| Stage | series_c |
| Total funding | $78,000,000 |
Website: www.gmaxbiopharm.com
Browse related
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account